Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III

Environmental Research

Volumn 110, Issue 1, 2010, Pages 105-111

  Gallagher, Carolyn M ^a,b   Moonga, Baljit S ^a   Kovach, John S ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BMD; Cadmium; FSH; Osteoporosis; Women

Indexed keywords

CADMIUM; FOLLITROPIN;

ABSORPTION; BODY MASS; BONE; CADMIUM; ENVIRONMENTAL RISK; ESTROGENIC COMPOUND; HEALTH GEOGRAPHY; HEALTH RISK; HORMONE; MULTIPLE REGRESSION; OSTEOLOGY; POLLUTION EXPOSURE; URINE; WOMENS HEALTH;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CLIMACTERIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENVIRONMENTAL EXPOSURE; FEMALE; FEMUR; FOLLITROPIN BLOOD LEVEL; HEALTH SURVEY; HORMONE ACTION; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; OUTCOMES RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; URINALYSIS; URINE LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; BODY BURDEN; BODY MASS INDEX; BONE DENSITY; CADMIUM; CREATININE; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; FOLLICLE STIMULATING HORMONE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; UNITED STATES;

NORTH AMERICA; UNITED STATES;

EID: 71249100193     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2009.09.012     Document Type: Article

References (51)

1. Akesson A., Bjellerup P., Lundh T., Lidfeldt J., Nerbrand C., Samlioe G., et al. Cadmium-induced effects on bone in a population-based study of women. Environ. Health Perspect. 114 6 (2006) 830-834
2. Akesson A., Julin B., and Wolk A. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res. 68 15 (2008) 6435-6441
3. ATSDR (Agency for Toxic Substances and Disease Registry). Toxicological Profile for Cadmium (1999), US Department of Health and Human Services, Public Health Service, Atlanta, GA. http://www.atsdr.cdc.gov/toxprofiles/tp5.html Available: 〈http://www.atsdr.cdc.gov/toxprofiles/tp5.html〉 (5 January 2008)
4. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 51 6 (1986) 1173-1182
5. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., et al. Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol. Cell. Encdocrinol. 264 1-2 (2007) 102-108
6. Brzoska M.M., and Moniuszko-Jakoniuk J. Disorders in bone metabolism of female rates chronically exposed to cadmium. Toxicol. Appl. Pharmacol. 202 1 (2005) 68-83
7. Burger H., Dudley E., Robertson D., and Dennerstein L. Hormonal changes in the menopause transition. Recent Prog. Horm. Res. 57 (2002) 257-275
8. CDC (Centers for Disease Control and Prevention), 2005. CDC's Third National Report on Human Exposure to Environmental Chemicals, Spotlight on Cadmium. NCEH Pub 05-0664, July.
9. CDC (Centers for Disease Control and Prevention), 2006. Analytic and Reporting Guidelines, The National Health and Nutrition Examination Survey (NHANES). National Center for Health Statistics (NCHS). Hyattsville, MD. Available at: 〈http://www.cdc.gov/nchs/nhanes.htm〉 (29 May 2008).
10. CDC (Centers for Disease Control and Prevention), 2008. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey III Data, 1988-1994. Available on line at: 〈http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm〉. (5 January 2008).
11. Comelekoglu U., Yalin S., Bagis S., Ogenier O., Sahin N.O., Yildiz A., et al. Low-exposure cadmium is more toxic on osteoporotic rat femoral bone: mechanical, biochemical, and histopathoogical evaluation. Ecotoxicol. Environ. Saf. 66 2 (2007) 267-271
12. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., et al. Bone turnover markers and bone density across the menopausal transition. J. Clin. Endocrinol. Metab. 81 9 (1996) 3366-3371
13. Friberg L., Elinder C.G., Kjellstrom T., and Nordberg G.F. Cadmium and Health: A Toxicological and Epidemiological Appraisal, Vol. 1, Exposure, Dose, and Metabolism (1985), CRC Press, Boca Raton, FL
14. Gallagher C.M., Kovach J.S., and Meliker J.R. Urinary cadmium and osteoporosis in US women ≥50 years of age: NHANES 1988-1994 and 1999-2004. Environ. Health Perspect. 116 10 (2008) 1338-1343
15. Greendale G.A., Edelstein S., and Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J. Bone Miner. Res. 12 11 (1997) 1833-1843
16. Hale G.E., and Burger H.G. Hormonal biomarkers in late reproductive age, menopausal transition and menopause. Best Pract. Res. Clin. Obstet. Gynaecol. 23 (2009) 7-23
17. Hooser S.B., Douds D.P., DeMerell D.G., Hoyer P.B., and Sipes I.G. Long-term ovarian and gonadotropin changes in mice exposed to 4-vinylcyclohexene. Reprod. Toxicol. 8 4 (1994) 315-323
18. Hoyer P.B. Damage to ovarian development and function. Cell Tissue Res. 322 (2005) 99-106
19. IPCS (International Programme on Chemical Safety), 1992. Environmental Health Criteria 134. Cadmium (ISBN 92-4-157134-9). Available: 〈http://www.inchem.org/documents/ehc/ehc134.htm〉 (26 December 2007).
20. Iqbal J., Sun L., Kumar T.R., Blair H.C., and Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA 103 40 (2006) 14925-14930
21. Khosla S., Atkinson E.J., Melton III L.J., and Riggs B.L. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J. Clin. Endocrinol. Metab. 82 5 (1997) 1522-1527
22. Khosla S., Melton III L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., and Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 83 7 (1998) 2266-2274
23. Khosla S., Riggs B.L., Robb R.A., Camp J.J., Achenbach S.J., Oberg A.L., et al. Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women. J. Clin. Endocrinol. Metab. 90 9 (2005) 5096-5103
24. Krum S.A., and Brown M. Unraveling estrogen action in osteoporosis. Cell Cycle 7 10 (2008) 1348-1352
25. Klaassen, C.D., 2008. Casarett and Doull's Toxicology: The Basic Science of Poisons. 7th Edition. The McGraw-Hill Companies, Inc. New York, USA.
26. Krum S.A., Mianda-Carboni G.A., Hauschka P.V., Carroll J.S., Lane T.F., Freedman L.P., and Brown M. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27 (2008) 535-545
27. Looker A.C., Orwoll E.S., Jonston C.C., Lindsay R.L., Wahner H.W., Dunn WL., et al. Prevalence of low femoral bone density in older US adults from NHANES III. J. Bone Miner. Res. 12 11 (1997) 1761-1768
28. Lu L., Nayeem F., Anderson K.E., Grady J.J., and Nagamani M. Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women. J. Nutr. 139 2 (2009) 250-256
29. Mahabir S., Baer D.J., Johnson L.L., Hartman T.J., Dorgan J.F., Campbell W.S., et al. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 15 12 (2006) 2502-2507
30. NOF (National Osteoporosis Foundation), 2009. Clinician's Guide to Prevention and Treatment of Osteoporosis. 〈http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf〉 (21 February 2009).
31. Paksy K., Rajczy K., Forgacs Z., Lazar P., Bernard A., Gati I., et al. Effect of cadmium on morphology and steroidogenesis of cultured human ovarian granulose cells. J. Appl. Toxicol. 17 5 (1997) 321-327
32. Perrien D.S., Achenbach S.J., Bledsoe S.E., Walser B., Suva L.J., Khosla S., et al. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 91 5 (2006) 1848-1854
33. Piasek M., Laskey J.W., Kostial K., and Blanusa M. Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue. Int. Arch. Occup. Environ. Health 75 Suppl (2002) s36-s44
34. Prior J.C. Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation. Endocrine 26 3 (2005) 297-300
35. Randolph Jr. J.F., Sowers M., Bondarenko I.V., Harlow S.D., Luborsky J.L., and Little R.J. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 89 4 (2004) 1555-1561
36. Regunathan A., Glesne D.A., Wilson A.K., Song J., Nicolae D., Flores T., et al. Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice. Toxicol. Appl. Pharmacol. 191 3 (2003) 272-293
37. Riggs B.L., Sundeep K., and Melton L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23 3 (2002) 279-302
38. Robertson D.M., Hale G.E., Jolley D., Fraser I.S., Hughes C.L., and Burger H.G. Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J. Clin. Endocrinol. Metab. 94 1 (2009) 138-144
39. Rothman K.J. Epidemiology: An Introduction (2002), Oxford University Press, New York
40. Schutte R., Nawrot T.S., Richart T., Thijs L., Vanderschueren D., Kuznetsova T., et al. Bone resorption and environmental exposure to cadmium in women: a population study. Environ. Health Perspect. 116 6 (2008) 777-783
41. Smith S.S., Reyes J.F., Arbon K.S., Harvey W.A., Hunt L.M., and Heggland S.J. Cadmium-induced decrease in RUNX2 mRNA expression and recovery by the antioxiant N-acetylcysteine (NAC) in the human osteoblast-like cell line Saos-2. Toxicol. In Vitro 23 1 (2009) 60-66
42. Simpson E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 86 3-5 (2003) 225-230
43. Sowers M.R., Greendale G.A., Bondarenko I., Finkelstein J.S., Cauley J.A., Neer B., et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporosis Int. 14 (2003) 191-197
44. Sowers M.R., Jannausch M., McConnell D., Little R., Greendale G.A., Finkelstein J.S., et al. Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metab. 91 4 (2006) 1261-1267
45. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., Zaidi S., et al. FSH directly regulates bone mass. Cell 125 (2006) 247-260
46. USDHHS (US Department of Health and Human Services). Bone Health and Osteoporosis: A Report of the Surgeon General (2004), US Department of Health and Human Services, Office of the Surgeon General, Rockville, MD
47. Vahter M., Berglund M., Akesson A., and Liden C. Metals and women's health. Environ. Res. 88 3 (2002) 145-155
48. Varga B., Zsoinai B., Paksy K., Naray M., and Ungvary G. Age dependent accumulation of cadmium in the human ovary. Reprod. Toxicol. 7 3 (1993) 225-228
49. Whittemore A.S., DiCiccio Y., and Provenzano G. Urinary cadmium and blood pressure: results from the NHANES II Survey. Environ. Health Perspect. 91 (1991) 133-140
50. WHO (World Health Organization), 2004. WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level, Summary Meeting Report. Brussels, Belgium, 5-7 May.
51. Zhang W., Pang F., Huang Y., Yan P., and Lin W. Cadmium exerts toxic effects on ovarian steroid hormone release in rats. Toxicol. Lett. 182 1-3 (2008) 18-23